Literature DB >> 4906723

Effect of large intermittent intravenous doses of cyclophosphamide in lymphoma.

D Mendelson, J B Block, A A Serpick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4906723     DOI： 10.1002/1097-0142(197003)25:3<715::aid-cncr2820250332>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

Review 1.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

2.  Excretion patterns of alkylating metabolites in urine following cyclophosphamide treatment of tumor patients: influence of application route, dosage, liver and kidney function.

Authors:  G Saul; M Matthias; H Rose; I Pradel
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

3.  Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.

Authors:  J Z Fuks; M J Egorin; J Aisner; S S Ostrow; M E Klein; N R Bachur; M Colvin; P H Wiernik
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.